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The phospholipid composition, the distribution of phospholipids over the two membrane layers as well as 
the phosphatidylcholine-specific transfer protein-mediated exchangeability of phosphatidylcholine from the 
membrane, has been investigated in two types of abnormal erythrocytes - the McLeod phenotype and the 
Leach phenotype. The acanthocytic McLeod cells appeared to have a normal phospholipid composition 
and distribution, but the exchangeability of phosphatidylcholine was found to be markedly enhanced. Un- 
like control erythrocytes, in which 75% of all of the phosphatidylcholine can be exchanged uring an 8 
h incubation, the McLeod cell showed a complete exchange of this phospholipid within the same time 
period. This obviously indicates an enhanced transbilayer mobility of phosphatidylcholine in the membrane 
of McLeod cells. Erythrocytes of the Leach phenotype showed an elliptocytic shape and increased osmotic 
fragility, but no abnormalities were observed as to the composition and organisation of the phospholipid 
complement of their membranes. 
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1. INTRODUCTION 
The specific composition and organisation of 
the lipid bilayer together with the numerous 
transmembrane proteins and its underlying 
cytoskeleton form the complex erythrocyte mem- 
brane. Evidence is accumulating that most of the 
individual constituents are indispensable for the 
maintenance of the stability, permeability and 
overall shape of the cell. This evidence has been 
obtained both from studies on erythrocytes which 
have been modified in vitro and from analyses car- 
ried out on naturally occurring abnormal cells [ 11. 
Several examples of the latter group of 
erythrocytes have abnormal blood group antigen 
expression. In the Rh,ll phenotype, the loss of the 
antigens of the Rhesus blood group system (as a 
result of the loss of two or more membrane pro- 
teins) is accompanied by changes in membrane 
permeability, increased osmotic fragility and ab- 
normal cell shape and also results in a distortion of 
membrane phospholipid organisation [2,3,19]. 
This study deals with two other red cell types which 
have abnormal expression of blood group an- 
tigens: the McLeod phenotype and the Leach 
phenotype. In McLeod erythrocytes, the Kell an- 
tigens are weakly expressed, and the cells show an 
acanthocytic morphology, a minor increase in 
osmotic fragility, and a decrease in water 
permeability [4-71. Cells of the Leach phenotype 
lack 3 minor sialoglycoproteins (6, ,61 and y IS]), 
and also the Gerbich blood group antigen. A pro- 
portion of these cells are elliptocytic [8]. 
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2. MATERIALS AND METHODS 
Erythrocytes of the McLeod phenotype from 
donors R.F. and R.E, erythrocytes from Leach 
phenotype donor P.L. and control normal 
erythrocytes were drawn in ACD anticoagulant. 
Erythrocytes were isolated by centrifugation for 
10 min at 2500 x g and washed 3 times with 4 vols 
of 150 mM NaCl. Osmotic fragility was deter- 
mined as described [9]. Cells were suspended in a 
buffer containing 10 mM Tris-HCl (pH 7.5), 
10 mM CaC12,0.25 mM MgClz and 150 mM NaCl 
for phospholipase incubations. For the phospha- 
tidylcholine exchange experiments the buffer con- 
tained 150 mM NaCl, 25 mM glucose, 1 mM 
EDTA, 100 IU penicillin/ml, 10O~g streptomy- 
cin/ml and 10 mM Tris-HCl, pH 7.4. Incubations 
with phospholipase AZ and sphingomyelinase C 
from Staphylococcus aureus were carried out as 
described [lo], except that in addition to the phos- 
pholipase A2 from Naja naja, an equal amount 
(enzyme units) of bee venom phospholipase AZ was 
present in the incubation mixtures. 
Following the incubation, phospholipids were 
extracted according to Rose and Oklander [l l] and 
analysed by thin-layer chromatography [12] and 
phosphate analysis [ 131. Exchange experiments 
were carried out as in [14] using [14C]phosphatidyl- 
choline-labelled microsomes from 
donor system. 
3. RESULTS AND DISCUSSION 
rat liver as 
Alterations in individual membrane consti- 
tuents, as is the case in the Leach and McLeod 
phenotypes studied here, can have far-reaching 
consequences on the overall properties of the cell 
membrane. Various parameters can be tested to il- 
lustrate this and in our studies we examined: (i) the 
osmotic fragility of the cells as an indication of 
membrane integrity; (ii) the overall shape of the 
erythrocytes; (iii) the phospholipid composition 
and distribution and (iv) the transbilayer mobility 
of the phosphatidylcholine. 
Red cells of the McLeod phenotype show 
decreased osmotic water permeability [6] but their 
osmotic fragility is close to normal, as shown in 
fig.1. A clearly abnormal haemolysis pattern is 
shown for cells of Leach phenotype which are 
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Fig. 1. Osmotic fragility of control and abnormal 
erythrocytes. A continuous dilution procedure [9] was 
used to measure the osmotic fragility of normal (o), 
McLeod (0) and Leach (A) erythrocytes. Data are 
plotted as percent haemolysis vs osmolarity, expressed as 
a percentage of iso-osmolarity (150 mosM). 
more fragile since they lyse at higher tonicity 
values than the control cells (fig.1). 
The overall shape of the two abnormal cells has 
been studied and the results confirm earlier obser- 
vations [6-81. About 10% of the Leach phenotype 
cells were elliptocytes, whereas 30% of McLeod 
phenotype cells showed an acanthocytic mor- 
phology. How these abnormalities in overall cell 
shape are correlated with defects in membrane 
structure is not clear. Comparison with other cell 
types in which integral membrane proteins are 
lacking may be relevant. Cells of the Leach 
phenotype lack 3 minor sialoglycoproteins and 
have abnormal shape. In contrast, abnormal‘cell 
shape has not been reported for either En(a -) 
erythrocytes which lack the major sialoglycopro- 
tein LY (glycophorin A) or homozygous Mk 
erythrocytes which lack sialoglycoproteins (Y and 6 
(glycophorin B) [15,16]. The differences could be 
due to the fact that the 3 minor sialoglycoproteins 
P, Pl and y are normally bound to the 
cytoskeleton, whereas sialoglycoproteins a and 6 
are not [17,18]. Thus, these 3 minor sialoglycopro- 
teins may contribute to proper membrane-protein 
skeleton interaction and help to confer a discoid 
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shape on the cell. In an analogous manner to cells 
of the Leach phenotype, Rh,n cells lack one or 
more membrane proteins which are attached to the 
cytoskeleton and also have an abnormal shape 
[2,19]. How cells of the McLeod phenotype fit into 
this pattern remains obscure, since the precise 
defect in these cells is not known. 
Evidence is accumulating that erythrocytes 
showing an abnormal shape may also exhibit an 
enhanced mobility of their membrane phospho- 
lipids [20,21]. Analyses of the total phospholipid 
content and overall phospholipid composition of 
cells of the McLeod and Leach phenotypes as well 
as their cholesterol/phospholipid ratios did not 
reveal any significant abnormalities when com- 
pared to normal erythrocytes (not shown). Incuba- 
tions with phospholipase A2 and/or sphingomy- 
elinase C resulted in both cases in the hydrolysis of 
80% of the sphingomyelin, 75-80% of the phos- 
phatidylcholine, 20-30070 of the phosphatidyletha- 
nolamine and none of the phosphatidylserine. 
These results are very similar to those found with 
normal red cells [22]. These observations indicate 
that the specific asymmetric distribution of eryth- 
rocyte phospholipids is maintained in these two 
abnormal cell types, despite their abnormal shape. 
Finally, a test was performed to estimate the trans- 
bilayer mobility of the membrane phospholipids, 
in particular phosphatidylcholine. This lipid, 75% 
of which is present in the outer layer of the eryth- 
rocyte membrane, can be exchanged for other 
phosphatidylcholine molecules originating from an 
exogenous donor system by using a specific trans- 
fer protein [14]. In fig.%, it is shown that in control 
cells 75% of the phosphatidylcholine is exchange- 
able and a similar value is found for the Leach 
phenotype. The clear plateau in the exchange pro- 
file shows that the residual 25% of this phos- 
pholipid present in the inner membrane layer does 
not become readily accessible for exchange. This 
implies that transbilayer mobility of the phosphati- 
dylcholine in the Leach phenotype cells is at least 
as slow as that in the normal red cells [14]. 
A different result is obtained with the McLeod 
cells in which the transbilayer mobility of 
phosphatidylcholine is enhanced to the extent that 
all of this lipid is exchangeable at a relatively fast 
rate and in this respect the McLeod cells resemble 
the Rh,,ii cells [3]. 
Table 1 summarises the data presented here and 
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Fig.2. Exchange of erythrocyte phosphatidylcholine. 
Cells were incubated with phosphatidylcholine-specific 
exchange protein and microsomal membranes as the 
[ “C]phosphatidylcholine donor. The extent of 
exchange, expressed as percent of the total 
phosphatidylcholine present in the erythrocyte, was 
determined at various time points for control (o), 
McLeod (0) and Leach (A) cells. The horizontal broken 
line shows the amount (75%) of phosphatidylcholine 
which is present in the outer layer of the erythrocyte 
membrane. 
those obtained previously for other phenotypes -
the En(a-) phenotype and the Rh,,ii phenotype. 
The conclusions which may be drawn from these 
studies are as follows: (i) a loss of particular in- 
tegral membrane proteins can result in a modifica- 
tion in the organisation of the lipid bilayer; (ii) in 
the case of En(a - ) erythrocytes where such a loss 
is not accompanied by changes in cell morphology 
no abnormalities in phospholipid distribution are 
found; (iii) absence of particular integral mem- 
brane proteins associated with abnormal cell mor- 
phology, viz. acanthocytes. (McLeod) stomato- 
cytes (Rh,,n) or elliptocytes (Leach), can have a 
variety of effects on the phospholipid bilayer. 
These range from effects on both phospholipid 
distribution and enhanced transbilayer phospho- 
lipid movement (Rh,,n cells), enhanced bilayer 
movement (McLeod) to no detectable effect 
(Leach). 
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Table 1 
Some characteristics of four types of human erythrocytes having an antigenic abnormality 
Cell type 
Rh,,rr 
Antigenic 
abnormality 
Absence of 
antigens of the 
Rhesus blood 
group system 
Morphology Osmotic Biochemical Organisation of the 
fragility membrane lipid bilayer 
relative to lesion 
normal cells Phospho- Percentage 
lipid dis- of PC ex- 
tribution changeable 
Stomatocytes Increased Integral protein(s) Abnormal 
bound to mem- with respect 
brane skeleton to PE 100 
absent 
McLeod Weak expression Acanthocytes Normal Normal 100 
of antigens of the 
Kell blood group 
system 
Leach Gerbich antigen 
absent 
Elliptocytes Increased Minor sialoglyco- Normal 75 
proteins bound to 
membrane skeleton 
absent 
En(a - ) MN antigens Normal Normal Glycophorin A Normal n.d. 
absent discocytes absent 
PC, phosphatidylcholine, PE, phosphatidylethanolamine; n.d., not determined; osmotic fragility is defined as the 
tonicity of the buffer at which 50% of the cells are haemolysed 
Although detailed interpretation of these results 
is not possible at this stage they suggest hat some 
of the minor membrane proteins, such as those ex- 
pressing Rhesus blood group antigens, specifically 
interact with the bilayer phospholipids, but that 
abnormal cell shape is not always correlated with 
alterations of the lipid bilayer. Lipid bilayer 
destabilisation has also been observed in other 
cells. Erythrocytes which show defined abnor- 
malities in the organisation of the skeletal network 
and/or its interaction with the membrane bilayer, 
i.e., spherocytes [23], sickle cells [20,21], and 
pyropoikilocytes (Franck et al., submitted). Thus a 
destabilisation of the lipid bilayer can be due to a 
defect in its interaction with the membrane 
skeleton, but the data obtained so far are not suffi- 
cient to allow a full understanding of how the 
absence of particular (minor) integral membrane 
proteins causes changes in cell shape and organisa- 
tion of phospholipids in the membrane bilayer. 
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